Strategic Asset Leasing Inc (OTCMKTS:LEAS) stock Gains Momentum: Here is Why

A stock rallying strongly despite there being no news is not a particularly uncommon phenomenon and such a thing happened with the Strategic Asset Leasing Inc (OTCMKTS:LEAS) stock on Friday. Last Friday, there was heavy action in the Strategic Asset Leasing stock as it ended the day with gains of much as 57%. In light of such gains, the Strategic Asset Leasing stock is likely to come into focus today…

Read More >>

Palisade Bio (NASDAQ:PALI) Stock Continues to Move Lower: Time to Buy?

Late-stage biopharmaceutical company focused on advancing therapies helping patients with acute and chronic gastrointestinal complications, Palisade Bio (NASDAQ:PALI) on July 29, 2021, announced entering into exclusive license with the Regents of the University of California. This will facilitate expansion of the technology to detect enzymatic protease activity in human clinical samples. In combination with 2020 license from University of California, the firm gets worldwide exclusive license for patent rights covering…

Read More >>

Atlas Technology Group Inc (OTCMKTS:ATYG) stock Rockets 805: But Why?

This past Friday, the Atlas Technology Group Inc (OTCMKTS:ATYG) stock emerged as one of the prime movers in the market as investors piled on to it in a big way. The stock ended the day with gains of as much as 80%. Despite the enormous gains made by the stock most investors will probably feel that the rally was largely speculative in nature since there was no news about the…

Read More >>

Why Sundial Growers (NASDAQ:SNDL) Stock Continues to Underperform? Time to Buy?

Sundial Growers (NASDAQ:SNDL) is having a challenging summer after jumping up to $4 in February 2021, and the stock has since been on a downward trend.  Surprisingly, in April, the stock dropped below $1 and has since struggled to keep any momentum. At the beginning of this year, investors on Reddit/WallStreetBets forum turned attention to the stock, but that fanfare has since cooled off. The company’s outlook has since changed,…

Read More >>

Will Castor Maritime (NASDAQ:CTRM) Stock Sees Buying Interest in August?

Castor Maritime (NASDAQ:CTRM) is currently traded at $2 as the stock has had a bumpy ride in recent times. The dry bulk shipping sector has not been doing well, but for optimistic investors feeling that the industry will do well in the coming months, it is worth looking elsewhere.  In June, CTRM was trading at around $3.35, but since then, the stock has lost almost 40% of its value and…

Read More >>

Will Zomedica (ZOM) Stock Recover After The Recent Fall?

Zomedica (NYSEAMERICAN:ZOM) is currently at $0.64 per share. It may seem like a considerable risk for investors especially considering that for a long period in 2020, the stock was trading under a dime. According to the company’s announcement of 2020 financial results, it is still in the development stage, and it has no revenue. The company reported a net loss of around $16.9 million or $0.05 per share. Ordinarily, most…

Read More >>

Tricida Inc. (NASDAQ:TCDA) Stock Sees Selling Pressure Ahead of Earnings: What Next?

Tricida Inc. (NASDAQ:TCDA) dropped 13% after the company announced that it would release its Q2 2021 financial results on August 9, 2021, after market close. In addition, the company will hold a webcast and conference call at 4:30 PM Eastern Time to discuss the Q2 financial results and company progress. Recently, the company released its Q1 2021 results for the period ended March 31, 2021, and offered an update on…

Read More >>

Abraxas Petroleum Corporation (NASDAQ:AXAS) Stock Is All Set To Gap-DOwn: Will it Recover?

Abraxas Petroleum Corporation (NASDAQ:AXAS) fell 17% pre-market following notice of delisting for failing to meet the continued NASDA listing rule. On May 11, 2021, and July 26, 2021, the Nasdaq Stock Market issued the company with notices indicating that the company was not complying with Nasdaq Listing Rule 5550(b) for continued listing. The May 11 notice indicated that as previously reported in Form 10—Q for the first quarter of 2021,…

Read More >>

PainReform Ltd. (NASDAQ:PRFX) Stock Falls Without Any News: Will It Rebound?

PainReform Ltd. (NASDAQ:PRFX) dropped 17% after a recent jump despite the company not releasing any news.  The company focuses on established drugs reformulation with an extended-release system vital in minimizing post-surgical pain. Retail traders in social media platforms have been citing PRFX’s low float as a catalyst to spur up momentum. That added to the speculation that PainReform is almost releasing its third Phase PRF-110 clinical trials results could be…

Read More >>
x